Global Platelet Rich Plasma Market to Value US$0.35 bn by 2020, Propelled by Rising Awareness in Developing Economies

Platelet rich plasma (PRP) is a blood plasma derived product, which typically contains an elevated level of platelets and growth factors (at least four to eight times) than normal blood concentration. Increasing number of orthopedic surgeries and sports injuries, rising number of cosmetic surgeries, approval of new devices and discovery of new application areas and growing awareness amongst the global population are the prime factors driving the growth of global PRP market. According to the statistics provided by the International Society of Plastic and Aesthetic Surgeons (ISAPS), 11 million non-invasive cosmetic procedures were performed worldwide in 2013, including approximately 3.0 million dermal filler procedures. This extensive number of cosmetic surgeries performed is considered as one of the most prominent factor propelling the growth of the global PRP market during the forecast period from 2014 to 2020.

Furthermore, increasing application areas such as erectile dysfunction and vampire facelift also support the market growth in the near future. However, high cost of the devices and therapy and threat of therapy failure are some of the factors restricting the market growth to some extent.

P-PRP (Pure-PRP) segment was identified as the largest type of PRP in 2013. Extensive use of P-PRP for orthopedic diseases and rich content of platelets and growth factors are expected to support the leadership position of the market segment. On the other hand, higher number of growth factors that promote rapid healing of injuries is likely to accelerate the L-PRF segment in the near future. In addition, cost effective platelet derivative, rich content of stem cells and leukocytes and high efficiency to treat diseases such as tendons and ligament injuries and neurological diseases are the other key factors that support the growth of L-PRF segment.

Get a Free Sample: http://bit.ly/1SNQA2S

On the basis of origin, autologus PRP accounted for the largest market share in 2013. Ease of production, cost-effectiveness and lowest threat of disease transfusion are some of prominent factors that contributed in the dominance of this market segment. However, allogenic PRP segment is anticipated to witness a strong growth rate during the forecast period owing to high concentration of growth factors coupled with reduced time of wound healing.

Orthopedic surgery was the largest application segment in 2013. Increasing prevalence of orthopedic diseases and promotion of PRP technique by various sports personalities are some of the factors responsible for the dominance of this application segment in the global PRP market. PRP products are widely used in cosmetic surgeries to improve facial aesthetics, enhance the rate of injury healing and modify facial structure (vampire facelift treatment). In addition, cosmetic surgeries performed with the use of PRP products modify the facial aesthetics in a short period of time due to reduction in the healing time. Thus, owing to all the above mentioned factors cosmetic surgery application segment is likely to witness the highest growth rate during the forecast period from 2014 to 2020.

Geographically, the platelet rich plasma market has been segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America accounted for the largest share in the global PRP market in 2013. The dominance of this region was majorly due to increasing prevalence of orthopedic diseases, growing cosmetic surgeries, approvals of various devices by the U.S. FDA and growing awareness among the patient population. However, Asia-Pacific is likely to witness the highest CAGR of more than 15.0% during the forecast period from 2014 to 2020. Rapidly increasing awareness about PRP products and expanding medical tourism are some of the major drivers of the PRP market in this region..

Major players having presence in the global PRP market include Harvest Technologies Corp., Biomet, Inc., Arthrex, Inc. and Arteriocyte Medical Systems, Inc. Other major players include Dr. PRP America, Cesca Therapeutics, Inc. and Regen Lab SA amongst others.

Browse Full Research Report: http://bit.ly/22vJZSO

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.